|
|
ProAuctum announces that the increase in value of the fund for February 2025 was -5.4% which regrettably was not only less than the -3.2% achieved by the ASX 100 index, but it was also negative. The shame is almost unbearable.
ProAuctum's,
ASX 100 Fund latest portfolio composition and monthly result to date
is displayed below
| March 2025 Portfolio Performance to Date: (from 28-Feb-25 ) |
| Stock |
Weight |
Initial Price |
Last price |
Increase |
Name |
| PME |
34.50% |
253.25 |
229.89 |
-9.22% |
Pro Medicus Ltd |
| PNI |
26.60% |
22.81 |
18.53 |
-18.76% |
Pinnacle Investment Management |
| TLX |
29.30% |
28.46 |
28.93 |
1.65% |
TELIX Pharmaceuticals |
| TNE |
9.60% |
29.47 |
28.70 |
-2.61% |
Technology One |
| ProAuctum |
100.00% |
100.00 |
92.06 |
-7.94% |
at 16:38 PM |
| ASX 100 |
100.00% |
6855.00 |
6667.00 |
-2.74% |
ASX 100 Index |
| Portfolio performance to date based on current prices sourced from Yahoo Finance and Alpha Vantage Tuesday, March 25, 2025 4:38:36 PM response time = 9.95 seconds. |
| ProAuctum Performance Record |
| Measure |
ProAuctum |
ASX 100 |
| 1-Year |
26.0%pa |
4.4%pa |
| 2-Year |
17.2%pa |
5.9%pa |
| 5-Year |
8.2%pa |
5.1%pa |
| Max period 19-years |
14.7%pa |
2.7%pa |
| Monthly record |
ProAuctum |
ASX 100 |
| Feb-25 |
-5.40% |
-3.20% |
| Jan-25 |
3.71% |
1.97% |
| Dec-24 |
-5.33% |
-2.13% |
| Nov-24 |
-1.13% |
3.09% |
| Oct-24 |
3.92% |
-0.19% |
| Sep-24 |
10.64% |
2.80% |
| Aug-24 |
-3.60% |
-1.30% |
| Jul-24 |
4.13% |
4.49% |
| Jun-24 |
13.90% |
-0.08% |
| May-24 |
3.88% |
2.53% |
| Apr-24 |
3.84% |
-3.02% |
| Mar-24 |
-3.70% |
-0.41% |
|
|
|
|
Visits updated
lblConn0
|
|
